The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes with ibrutinib by line of therapy in patients with CLL: Analyses from phase III data.
 
Susan Mary O'Brien
Honoraria - Celgene; Gilead Sciences; Janssen; Pfizer; Pharmacyclics; ProNAi; Regeneron
Consulting or Advisory Role - Amgen; Celgene; CLL Global Research Foundation
Research Funding - Acerta Pharma; Gilead Sciences; Regeneron
Travel, Accommodations, Expenses - Celgene; Gilead Sciences; Janssen; Regeneron
 
John C. Byrd
No Relationships to Disclose
 
Peter Hillmen
Honoraria - AbbVie; Gilead Sciences; GlaxoSmithKline; Janssen; Novartis; Pharmacyclics; Roche
Consulting or Advisory Role - AbbVie; Gilead Sciences; GlaxoSmithKline; Janssen; Roche
Research Funding - AbbVie; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Novartis; Pharmacyclics; Roche
 
Steven Coutre
Stock and Other Ownership Interests - Pharmacyclics (I)
Consulting or Advisory Role - Abbvie; Celgene; Genentech/Roche; Gilead Sciences; Novartis; Pharmacyclics
Research Funding - Abbvie (Inst); Celgene (Inst); Gilead Sciences (Inst); Novartis (Inst); Pharmacyclics (Inst)
Travel, Accommodations, Expenses - abbvie; Celgene; Gilead Sciences; Novartis; Pharmacyclics
 
Jennifer R. Brown
Consulting or Advisory Role - Boehringer Ingelheim; Celgene; Gilead Sciences; Infinity Pharmaceuticals; Janssen; Pharmacyclics; ProNAi; Roche/Genentech; Sun Pharma
 
Paul M. Barr
Consulting or Advisory Role - Abbvie; Genentech; Pharmacyclics; Seagen
Research Funding - Pharmacyclics (Inst)
 
Jacqueline Claudia Barrientos
Research Funding - AbbVie (Inst); Gilead Sciences (Inst); Pharmacyclics (Inst)
 
Stephen Devereux
Consulting or Advisory Role - Gilead Sciences; GlaxoSmithKline; Janssen; Roche
Speakers' Bureau - Gilead Sciences; Janssen
Travel, Accommodations, Expenses - Gilead Sciences; Janssen; Roche
 
Tadeusz Robak
Honoraria - Janssen
Consulting or Advisory Role - Janssen
Research Funding - Janssen; Pharmacyclics
 
Nishitha M. Reddy
Consulting or Advisory Role - Celgene; Pharmacyclics; Seagen
 
Thomas J. Kipps
Consulting or Advisory Role - AbbVie; Genentech; Gilead Sciences
Research Funding - AbbVie; Genentech; Pharmacyclics
 
Alessandra Tedeschi
No Relationships to Disclose
 
Florence Cymbalista
Honoraria - Gilead Sciences; Janssen; Karyopharm Therapeutics; Mundipharma
Consulting or Advisory Role - Gilead Sciences; Janssen
Research Funding - Celgene; Janssen
Travel, Accommodations, Expenses - Janssen; Mundipharma; Roche
 
Paolo Ghia
Consulting or Advisory Role - AbbVie; Adaptive Biotechnologies; Gilead Sciences; Janssen; Pharmacyclics; Roche
Speakers' Bureau - Gilead Sciences
Research Funding - Gilead Sciences; GlaxoSmithKline; Roche
 
Stephen Chang
Employment - Pharmacyclics
Stock and Other Ownership Interests - AbbVie
 
Joi Suzuki Ninomoto
Employment - Pharmacyclics
Stock and Other Ownership Interests - Amgen; Pharmacyclics
 
Danelle Frances James
Employment - Pharmacyclics
Stock and Other Ownership Interests - Abbvie
 
Jan Andreas Burger
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Gilead Sciences; Infinity Pharmaceuticals; Janssen; Pharmacyclics
Research Funding - Celgene (Inst); Gilead Sciences (Inst); Pharmacyclics (Inst); Portola Pharmaceuticals (Inst); TG Therapeutics (Inst)